
Group 1 - Centrus Energy is a unique investment opportunity as it is one of only two U.S. suppliers licensed to produce low-enriched uranium (LEU) and the only one for high-assay low-enriched uranium (HALEU) [1] - The stock has seen a significant increase, up 323% year-to-date and over 470% year-over-year, but its future growth depends on the company's execution and favorable policy conditions [2] - Centrus operates as a nuclear fuel supplier, providing LEU through long-term purchase agreements, and has recently started operations at the American Centrifuge Plant, the first U.S.-owned enrichment plant to begin production since 1954 [4] Group 2 - The American Centrifuge Plant is currently the only U.S. facility licensed to produce HALEU, which is essential for next-generation reactors, addressing the need for domestic production due to previous reliance on foreign sources [5] - Centrus has a contract with the U.S. Department of Energy to produce HALEU, having delivered 900 kilograms in mid-June, with plans for additional deliveries through June 30, 2026 [6] - The company's market capitalization increased from approximately $684 million to over $5.5 billion between mid-2024 and mid-2025, largely due to policy support and HALEU deliveries, despite a slight decrease in net income during the same period [9]